Jeroen is Chief Commercial Officer for an ElevateBio Portfolio Company.
Prior to ElevateBio, Jeroen was Chief Commercial Officer and Senior Vice-President at Tricida in charge of commercial strategy, planning and operations. While there, he helped raise $256M in the company’s successful IPO, resulting in a > $1B market capitalization. Previous to Tricida, Jerone spent 10 years with Alexion Pharmaceuticals. As Vice-President of Global Commercial Operations and Development , he was in charge of the global Soliris® franchise, with sales of over $3 billion annually. He was responsible for the life-cycle management of Soliris® and the commercial development and positioning of Alexion’s portfolio of next-generation complement inhibitors. During his tenure at Alexion, Jeroen led the industry-leading launches for Soliris® in two rare diseases: the blood disorder Paroxysmal Nocturnal Hemoglobinuria and the kidney disease atypical Hemolytic Uremic Syndrome.
Education & Accomplishments
Jeroen received his B.S. in Chemistry from the University of Virginia, his Ph.D. in Chemistry from Cornell University, and his M.B.A. from the Darden Business School at the University of Virginia.
Interested in working with people like Jerone? We’re looking for pioneers and innovative thinkers committed to developing the next-generation of cell and gene therapies. Review our open roles and find your future.